Aller au contenuAller au pied de page
      employer cover photo
      employer logo
      employer logo

      Merck

      Est-ce votre entreprise ?

      Avis sur Merck

      Merck Research Lab -- extreme inefficiency - Avis employé Associate Principal Scientist Merck

      2,0
      16 août 2013
      Associate principal scientist
      Recommande
      Approbation du PDG
      Perspective commerciale

      Avantages

      Many smart scientists still work at Merck, especially below the Executive Director, and probably below the Director levels.

      Inconvénients

      Instability over the last 5 years that leads to direction changes every 8 months (especially in Oncology). Complete incompetence and lack of any vision at the highest management levels (people like Rich Tillyer) -- they use the company to exercise their huge egos, while destroying any real science and innovation. A lot of incompetence at the lower management levels (Executive Directors, Directors). Extreme inefficiency of the decision making process -- all power brokers need to be satisfied, leading to bad decisions. Good scientist and good science are not respected.

      Découvrez plus d’avis sur Merck

      5,0
      30 juin 2026
      Business analyst
      Recommande
      Approbation du PDG
      Perspective commerciale

      Avantages

      Excellent company to work with.

      Inconvénients

      No cons encountered so far

      4,0
      30 juin 2026
      Senior scientist i
      Recommande
      Approbation du PDG
      Perspective commerciale

      Avantages

      Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

      Inconvénients

      Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

      Voir les avis par: Utile|Évaluation|Date|Tout
      Recherches associées: Offres d’emploi chez Merck | Salaires chez Merck | Avantages sociaux chez Merck | Entretiens chez Merck
      Avis sur MerckAvis pour Associate Principal Scientist chez MerckAvis sur Merck